Search

Taeyoon Kim

Examiner (ID: 6346, Phone: (571)272-9041 , Office: P/1651 )

Most Active Art Unit
1651
Art Unit(s)
1632, 1651, 1631
Total Applications
1178
Issued Applications
467
Pending Applications
171
Abandoned Applications
584

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14990919 [patent_doc_number] => 20190314417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => IMMUNOSUPPRESSIVE MESENCHYMAL CELLS AND METHODS FOR FORMING SAME [patent_app_type] => utility [patent_app_number] => 16/395995 [patent_app_country] => US [patent_app_date] => 2019-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395995 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/395995
IMMUNOSUPPRESSIVE MESENCHYMAL CELLS AND METHODS FOR FORMING SAME Apr 25, 2019 Abandoned
Array ( [id] => 16726523 [patent_doc_number] => 20210093670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS [patent_app_type] => utility [patent_app_number] => 17/044045 [patent_app_country] => US [patent_app_date] => 2019-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5869 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044045 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044045
MATERIALS AND METHODS FOR THE TREATMENT OF LEWY BODY DISORDERS Apr 2, 2019 Pending
Array ( [id] => 15493245 [patent_doc_number] => 20200046811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => METHODS AND COMPOSITIONS FOR MODULATING FGF23 LEVELS [patent_app_type] => utility [patent_app_number] => 16/360244 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360244 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/360244
METHODS AND COMPOSITIONS FOR MODULATING FGF23 LEVELS Mar 20, 2019 Abandoned
Array ( [id] => 14531659 [patent_doc_number] => 20190201450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => Method for Treating Multiple Sclerosis [patent_app_type] => utility [patent_app_number] => 16/353127 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11186 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353127 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/353127
Method for treating multiple sclerosis Mar 13, 2019 Issued
Array ( [id] => 14535125 [patent_doc_number] => 20190203184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM [patent_app_type] => utility [patent_app_number] => 16/294223 [patent_app_country] => US [patent_app_date] => 2019-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4981 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294223 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/294223
OPTIMIZED METHOD FOR LARGE SCALE PRODUCTION OF PARVOVIRUS H-1 IN AN ESSENTIALLY SERUM-FREE MEDIUM Mar 5, 2019 Abandoned
Array ( [id] => 14497233 [patent_doc_number] => 20190192271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => CELL-CONTAINING SHEET [patent_app_type] => utility [patent_app_number] => 16/288790 [patent_app_country] => US [patent_app_date] => 2019-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24137 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288790 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/288790
CELL-CONTAINING SHEET Feb 27, 2019 Abandoned
Array ( [id] => 16569113 [patent_doc_number] => 20210008119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => ALLOGENEIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/969558 [patent_app_country] => US [patent_app_date] => 2019-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969558 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/969558
ALLOGENEIC COMPOSITION Feb 14, 2019 Abandoned
Array ( [id] => 14407463 [patent_doc_number] => 20190169575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME [patent_app_type] => utility [patent_app_number] => 16/273076 [patent_app_country] => US [patent_app_date] => 2019-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16273076 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/273076
SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME Feb 10, 2019 Abandoned
Array ( [id] => 14407453 [patent_doc_number] => 20190169570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => METHOD FOR MANUFACTURING CILIARY MARGINAL ZONE-LIKE STRUCTURE [patent_app_type] => utility [patent_app_number] => 16/267948 [patent_app_country] => US [patent_app_date] => 2019-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12595 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16267948 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/267948
Method for manufacturing ciliary marginal zone-like structure Feb 4, 2019 Issued
Array ( [id] => 14403769 [patent_doc_number] => 20190167728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs [patent_app_type] => utility [patent_app_number] => 16/263060 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263060 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/263060
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs Jan 30, 2019 Abandoned
Array ( [id] => 16619161 [patent_doc_number] => 20210037814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => DEVICE AND METHOD FOR FREEZE DRYING BIOLOGICAL SAMPLES [patent_app_type] => utility [patent_app_number] => 16/963974 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963974 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/963974
DEVICE AND METHOD FOR FREEZE DRYING BIOLOGICAL SAMPLES Jan 10, 2019 Abandoned
Array ( [id] => 18886385 [patent_doc_number] => 11865141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Composition for improving, preventing or treating skin disease comprising induced pluripotency stem cell-derived mesenchymal stem cells pretreated with interferon gamma and exosomes derived therefrom [patent_app_type] => utility [patent_app_number] => 16/959366 [patent_app_country] => US [patent_app_date] => 2019-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 7233 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959366 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/959366
Composition for improving, preventing or treating skin disease comprising induced pluripotency stem cell-derived mesenchymal stem cells pretreated with interferon gamma and exosomes derived therefrom Jan 6, 2019 Issued
Array ( [id] => 14277821 [patent_doc_number] => 20190136195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF [patent_app_type] => utility [patent_app_number] => 16/237399 [patent_app_country] => US [patent_app_date] => 2018-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6119 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16237399 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/237399
COMPOSITION FOR TREATING TENDONITIS AND MANUFACTURE THEREOF Dec 30, 2018 Abandoned
Array ( [id] => 16451018 [patent_doc_number] => 20200360444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => CELL POPULATION INCLUDING ADHESIVE STEM CELLS, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/958117 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958117 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/958117
CELL POPULATION INCLUDING ADHESIVE STEM CELLS, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION Dec 27, 2018 Abandoned
Array ( [id] => 15711563 [patent_doc_number] => 20200102547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => REPROSOMES, AS EXOSOMES CAPABLE OF INDUCING REPROGRAMMING OF CELLS AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 16/230242 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230242 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/230242
REPROSOMES, AS EXOSOMES CAPABLE OF INDUCING REPROGRAMMING OF CELLS AND PREPARATION METHOD THEREOF Dec 20, 2018 Abandoned
Array ( [id] => 14581799 [patent_doc_number] => 20190218508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => METHODS OF CELL SEPARATION [patent_app_type] => utility [patent_app_number] => 16/226544 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16226544 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/226544
METHODS OF CELL SEPARATION Dec 18, 2018 Abandoned
Array ( [id] => 14468517 [patent_doc_number] => 20190185901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => SAMPLE PROCESSING METHOD AND SAMPLE CULTURING METHOD [patent_app_type] => utility [patent_app_number] => 16/222862 [patent_app_country] => US [patent_app_date] => 2018-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7756 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222862 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/222862
Sample processing method and sample culturing method Dec 16, 2018 Issued
Array ( [id] => 16939903 [patent_doc_number] => 11052118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Enhanced stem cell composition [patent_app_type] => utility [patent_app_number] => 16/218314 [patent_app_country] => US [patent_app_date] => 2018-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30867 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16218314 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/218314
Enhanced stem cell composition Dec 11, 2018 Issued
Array ( [id] => 16948389 [patent_doc_number] => 20210207080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SERUM-FREE MEDIA FORMULATION FOR CULTURING CELLS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/770052 [patent_app_country] => US [patent_app_date] => 2018-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -99 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770052 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/770052
SERUM-FREE MEDIA FORMULATION FOR CULTURING CELLS AND METHODS OF USE THEREOF Dec 6, 2018 Pending
Array ( [id] => 16312621 [patent_doc_number] => 20200291359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-17 [patent_title] => ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 16/768203 [patent_app_country] => US [patent_app_date] => 2018-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17197 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768203 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/768203
Ectodermal mesenchymal stem cells and method for producing same Nov 29, 2018 Issued
Menu